SFI
ALNY icon

Siemens Fonds Invest’s Alnylam Pharmaceuticals ALNY Stock Holding History

Siemens Fonds Invest’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$939K Buy
2,838
+1,001
+54% +$341K 0.05% 245
2025
Q4 		$730K Hold
1,837
– – 0.04% 280
2025
Q3 		$838K Sell
1,837
-6
-0.3% -$2.44K 0.05% 252
2025
Q2 		$601K Buy
1,843
+372
+25% +$103K 0.04% 289
2025
Q1 		$397K Buy
1,471
+106
+8% +$27.2K 0.03% 314
2024
Q4 		$322K Hold
1,365
– – 0.02% 368
2024
Q3 		$375K Buy
+1,365
New +$355K 0.03% 318

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Siemens Fonds Invest's ALNY Position: Q1 2026 in Review

Siemens Fonds Invest increased its Alnylam Pharmaceuticals (ALNY) stake by 54% in Q1 2026, buying an estimated $341K and bringing the position to 2,838 shares worth $939K. The position accounts for 0.05% of the portfolio, ranked #245.

Siemens Fonds Invest first reported a position in ALNY in Q3 2024 and has held it in 7 quarters since. 787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Siemens Fonds Invest held 2,838 shares of Alnylam Pharmaceuticals worth $939K as of Q1 2026.
  • Siemens Fonds Invest bought 1,001 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $341K.
  • Alnylam Pharmaceuticals made up 0.05% of Siemens Fonds Invest's portfolio in Q1 2026, its #245 holding.
  • Siemens Fonds Invest first reported a position in Alnylam Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Siemens Fonds Invest's 13F filing for Q1 2026, filed 15 May 2026.